HOURS

HOURS is an artificial intelligence industrial scenario solutions provider, mainly serving pharmaceutical CRO/CMO/new drug discovery companies. It has developed an intelligent synthesis route and process design platform for new drug small molecules, offering a full-process product range from data to research and development, and production. Its capabilities cover the entire spectrum from laboratory processes to process design and scale-up production. The company utilizes world-leading AI process modeling and optimization algorithms, based on a multistage stochastic programming model (Multistage Stochastic Programming). Its core technical methods include deep learning (Deep Learning), machine learning (Machine Learning), and operations research algorithms (Operations Research), among others. HOURS aims to create value for customers by exploring process decision spaces, reducing uncertainty, and leveraging data and algorithms to bring significant improvements in revenue, efficiency, and cost under complex and uncertain real-world scenarios. Furthermore, it provides better, faster, and safer production, design, and operational solutions by gaining deeper insights into industrial decision-making processes. HOURS is committed to empowering pharmaceutical R&D with artificial intelligence technology.